Back to search
FDAFDA · Food and drugs·Recall number D-0503-2025

LIDOcaine HCL Sterile Injection, USP, 20 mg/mL, 2%, (200 mg/10 mL), For Infiltration & Nerve Block, Including Caudal & Epidural Use, Preservative Free, 10mL Sterile Single-Dose Vial, Rx Only, Medivant Healthcare, 158 S. Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0001-0.

Published July 9, 2025 · Recall initiated: June 2, 2025

Summary

FDA records drug Class II recall D-0503-2025, published July 9, 2025 and initiated June 2, 2025. Recalling firm: Tailstorm Health INC; Status: Ongoing; Reported quantity: 4875 vials; Lot: Lot #: 2504003, Exp. 04/03/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Tailstorm Health INC
Distributor
Nationwide in the US
Lot
Lot #: 2504003, Exp. 04/03/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was LIDOcaine HCL Sterile Injection, USP, 20 mg/mL, 2%, (200 mg/10 mL), For Infiltration & Nerve Block, Including Caudal & Epidural Use, Preservative Free, 10mL Sterile Single-Dose Vial, Rx Only, Medivant Healthcare, 158 S. Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0001-0. recalled?

Yes. FDA published recall D-0503-2025 on July 9, 2025. Reported hazard: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

What should I do if I have this product?

Voluntary: Firm initiated